Colorectal Cancer
Copyright ©2008 The WJG Press and Baishideng.
World J Gastroenterol. Sep 7, 2008; 14(33): 5162-5175
Published online Sep 7, 2008. doi: 10.3748/wjg.14.5162
Table 6 Analysis of the combined effects of doxorubicin and Rosco on human colorectal cancer cell lines
Combined treatment of doxorubicin and RoscoCombination interaction at various durations of treatment in human colorectal cancer cells1
SW48SW1116SW837
2 d4 d6 d2 d4 d6 d2 d4 d6 d
Dox 0.5 IC50 + Rosco 1.0 μg/mLantantantsynsynsynsynsynsyn
Dox 1.0 IC50 + Rosco 10 μg/mLantantantsynsynsynsynsynsyn
Dox 2.0 IC50 + Rosco 15 μg/mLantantantsynsynsynsynsynsyn
Dox 3.0 IC50 + Rosco 20 μg/mLantaddaddsynsynaddsynsynadd
Dox 4.0 IC50 + Rosco 25 μg/mLantaddaddsynantaddsynantant